Sestryny jako modulatory procesów starzenia i chorób związanych z wiekiem*
References
- Averous J., Fonseca B.D., Proud C.G.: Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1. Oncogene, 2008; 27: 1106–1113
- Bae E.J., Xu J., Oh D.Y., Bandyopadhyay G., Lagakos W.S., Keshwani M., Olefsky J.M.: Liver-specific p70 S6 kinase depletion protects against hepatic steatosis and systemic insulin resistance. J. Biol. Chem., 2012; 287: 18769–18780
- Bae S.H., Sung S.H., Oh S.Y., Lim J.M., Lee S.K., Park Y.N., Lee H.E., Kang D., Rhee S.G.: Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage. Cell Metab., 2013; 17: 73–84
- Blokh D., Stambler I.: The application of information theory for the research of aging and aging-related diseases. Prog. Neurobiol., 2017; 157: 158–173
- Budanov A.V.: Stress-responsive sestrins link p53 with redox regulation and mammalian target of rapamycin signaling. Anti-oxid. Redox Signal., 2011; 15: 1679–1690
- Budanov A.V., Karin M.: p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell, 2008; 134: 451–460
- Budanov A.V., Kovaleva I., Tokarchuk A., Zheltukhin A.O., Dalina A.A., Lyamzaev K.G., Haidurov A., Chumakov P.M.: Mitochondrial localization and function of SESN2. FASEB J., 2020; 34: 1
- Budanov A.V., Lee J.H., Karin M.: Stressin’ Sestrins take an aging fight. EMBO Mol. Med., 2010; 2: 388–400
- Budanov A.V., Shoshani T., Faerman A., Zelin E., Kamer I., Kalinski H., Gorodin S., Fishman A., Chajut A., Einat P., Skaliter R., Gudkov A.V., Chumakov P.M., Feinstein E.: Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene, 2002; 21: 6017–6031
- Buendia I., Michalska P., Navarro E., Gameiro I., Egea J., León R.: Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol. Ther., 2016; 157: 84–104
- Çelik H., Karahan H., Kelicen-Uğur P.: Effect of atorvastatin on Aβ1-42-induced alteration of SESN2, SIRT1, LC3II and TPP1 protein expressions in neuronal cell cultures. J. Pharm. Pharmacol., 2020; 72: 424–436
- Chai D., Wang G., Zhou Z., Yang H., Yu Z.: Insulin increases Sestrin 2 content by reducing its degradation through the PI3K/mTOR signaling pathway. Int. J. Endocrinol., 2015; 2015: 505849
- Chan E.Y.: Regulation and function of uncoordinated-51 like kinase proteins. Antioxid. Redox Signal., 2012; 17: 775–785
- Chen C.C., Jeon S.M., Bhaskar P.T., Nogueira V., Sundararajan D., Tonic I., Park Y., Hay N.: FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor. Dev. Cell, 2010; 18: 592–604
- Chen H., Wang X., Tong M., Wu D., Wu S., Chen J., Wang X., Wang X., Kang Y., Tang H., Tang C., Jiang W.: Intermedin suppresses pressure overload cardiac hypertrophy through activation of autophagy. PLoS One, 2013; 8: e64757
- Chen K.B., Xuan Y., Shi W.J., Chi F., Xing R., Zeng Y.C.: Sestrin2 expression is a favorable prognostic factor in patients with non-small cell lung cancer. Am. J. Transl. Res., 2016; 8: 1903–1909
- Chen S.D., Yang J.L., Lin T.K., Yang D.I.: Emerging roles of sestrins in neurodegenerative diseases: Counteracting oxidative stress and beyond. J. Clin. Med., 2019; 8: 1001
- Chen Y.R., Zweier J.L.: Cardiac mitochondria and reactive oxygen species generation. Circ. Res., 2014; 114: 524–537
- Chen Y.S., Chen S.D., Wu C.L., Huang S.S., Yang D.I.: Induction of sestrin2 as an endogenous protective mechanism against amyloid beta-peptide neurotoxicity in primary cortical culture. Exp. Neurol., 2014; 253: 63–71
- Cheung P.C., Salt I.P., Davies S.P., Hardie D.G., Carling D.: Characterization of AMP-activated protein kinase gamma-subunit iso-forms and their role in AMP binding. Biochem. J., 2000; 346: 659–669
- Cordani M., Sánchez-Álvarez M., Strippoli R., Bazhin A.V., Donadelli M.: Sestrins at the interface of ROS control and autophagy regulation in health and disease. Oxid. Med. Cell. Longev., 2019; 2019: 1283075
- Costanzo-Garvey D.L., Pfluger P.T., Dougherty M.K., Stock J.L., Boehm M., Chaika O., Fernandez M.R., Fisher K., Kortum R.L., Hong E.G., Jun J.Y., Ko H.J., Schreiner A., Volle D.J., Treece T. i wsp.: KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. Cell Metab., 2009; 10: 366–378
- Crute B.E., Seefeld K., Gamble J., Kemp B.E., Witters L.A.: Functional domains of the α1 catalytic subunit of the AMP-activated protein kinase. J. Biol. Chem., 1998; 273: 35347–35354
- Cuervo A.M., Macian F.: Autophagy and the immune function in aging. Curr. Opin. Immunol., 2014; 29: 97–104
- Ding B., Parmigiani A., Yang C., Budanov A.V.: Sestrin2 facilitates death receptor-induced apoptosis in lung adenocarcinoma cells through regulation of XIAP degradation. Cell Cycle, 2015; 14: 3231–3241
- Dong B., Xue R., Sun Y., Dong Y., Liu C.: Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2. Mol. Cell Biochem., 2017; 433: 113–123
- Fan W., Tang Z., Chen D., Moughon D., Ding X., Chen S., Zhu M., Zhong Q.: Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy. Autophagy, 2010; 6: 614–621
- Finkel T., Holbrook N.J.: Oxidants, oxidative stress and the biology of ageing. Nature, 2000; 408: 239–247
- Gabryel B., Kost A., Kasprowska D.: Neuronal autophagy in cerebral ischemia – a potential target for neuroprotective strategies? Pharmacol. Rep., 2012; 64: 1–15
- Gkikas I., Petratou D., Tavernarakis N.: Longevity pathways and memory aging. Front Genet., 2014; 5: 155
- Hardie D.G., Ross F.A., Hawley S.A.: AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol., 2012; 13: 251–262
- Hosokawa N., Hara T., Kaizuka T., Kishi C., Takamura A., Miura Y., Iemura S., Natsume T., Takehana K., Yamada N., Guan J.L., Oshiro N., Mizushima N.: Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell, 2009; 20: 1981–1991
- Hou Y.S., Guan J.J., Xu H.D., Wu F., Sheng R., Qin Z.H.: Sestrin2 protects dopaminergic cells against rotenone toxicity through AMPK-dependent autophagy activation. Mol. Cell. Biol., 2015; 35: 2740–2751
- Howell J.J., Manning B.D.: mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends Endocrinol. Metab., 2011; 22: 94–102
- Hwang H.J., Jung T.W., Choi J.H., Lee H.J., Chung H.S., Seo J.A., Kim S.G., Kim N.H., Choi K.M., Choi D.S., Baik S.H., Yoo H.J.: Knockdown of sestrin2 increases pro-inflammatory reactions and ER stress in the endothelium via an AMPK dependent mechanism. Biochim. Biophys. Acta, 2017; 1863: 1436–1444
- Hybertson B.M., Gao B., Bose S.K., McCord J.M.: Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation. Mol. Aspects Med., 2011; 32: 234–246
- Inoki K., Guan K.L.: Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. Hum. Mol. Genet., 2009; 18: R94–R100
- Kansanen E., Kuosmanen S.M., Leinonen H., Levonen A.L.: The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biol., 2013; 1: 45–49
- Karpińska A., Gromadzka G.: Stres oksydacyjny i naturalne mechanizmy antyoksydacyjne – znaczenie w procesie neurodegeneracji. Od mechanizmów molekularnych do strategii terapeutycznych. Postępy Hig. Med. Dośw., 2013; 67: 43–53
- Kim G.T., Lee S.H., Kim Y.M.: Quercetin regulates sestrin 2-AMPK-mTOR signaling pathway and induces apoptosis via increased intracellular ROS in HCT116 colon cancer cells. J. Cancer Prev., 2013; 18: 264–270
- Kim H., An S., Ro S.H., Teixeira F., Park G.J., Kim C., Cho C.S., Kim J.S., Jakob U., Lee J.H., Cho U.S.: Janus-faced Sestrin2 controls ROS and mTOR signalling through two separate functional domains. Nat. Commun., 2015; 6: 10025
- Kim H., Yin K., Falcon D.M., Xue X.: The interaction of Hemin and Sestrin2 modulates oxidative stress and colon tumor growth. Toxicol. Appl. Pharmacol., 2019; 374: 77–85
- Kim J., Kundu M., Viollet B., Guan K.L.: AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol., 2011; 13: 132–141
- Kim M., Sujkowski A., Namkoong S., Gu B., Cobb T., Kim B., Kowalsky A.H., Cho C.S., Semple I., Ro S.H., Davis C., Brooks S.V., Karin M., Wessells R.J., Lee J.H.: Sestrins are evolutionarily conserved mediators of exercise benefits. Nat. Commun., 2020; 11: 190
- Kim M.J., Bae S.H., Ryu J.C., Kwon Y., Oh J.H., Kwon J., Moon J.S., Kim K., Miyawaki A., Lee M.G., Shin J., Kim Y.S., Kim C.H., Ryter S.W., Choi A.M. i wsp.: SESN2/sestrin2 suppresses sepsis by inducing mitophagy and inhibiting NLRP3 activation in macrophages. Autophagy, 2016; 12: 1272–1291
- Kovaleva I.E., Tokarchuk A.V., Zheltukhin A.O., Dalina A.A., Safronov G.G., Evstafieva A.G., Lyamzaev K.G., Chumakov P.M., Budanov A.V.: Mitochondrial localization of SESN2. PLoS One, 2020; 15: e0226862
- Laplante M., Sabatini D.M.: mTOR signaling at a glance. J. Cell Sci., 2009; 122: 3589–3594
- Lee J.H., Budanov A.V., Karin M.: Sestrins orchestrate cellular metabolism to attenuate aging. Cell Metab., 2013; 18: 792–801
- Lee J.H., Budanov A.V., Park E.J., Birse R., Kim T.E., Perkins G.A., Ocorr K., Ellisman M.H., Bodmer R., Bier E., Karin M.: Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science, 2010; 327: 1223–1228
- Lee J.H., Budanov A.V., Talukdar S., Park E.J., Park H.L., Park H.W., Bandyopadhyay G., Li N., Aghajan M., Jang I., Wolfe A.M., Perkins G.A., Ellisman M.H., Bier E., Scadeng M. i wsp.: Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3. Cell Metab., 2012; 16: 311–321
- Liao H.H., Ruan J.Y., Liu H.J., Liu Y., Feng H., Tang Q.Z.: Sestrin family may play important roles in the regulation of cardiac pathophysiology. Int. J. Cardiol., 2016; 202: 183–184
- Liu G.Y., Sabatini D.M.: mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol., 2020; 21: 183–203
- Liu X., Niu Y., Yuan H., Huang J., Fu L.: AMPK binds to Sestrins and mediates the effect of exercise to increase insulin-sensitivity through autophagy. Metabolism, 2015; 64: 658–665
- López-Otín C., Blasco M.A., Partridge L., Serrano M., Kroemer G.: The hallmarks of aging. Cell, 2013; 153: 1194–1217
- Mamane Y., Petroulakis E., Rong L., Yoshida K., Ler L.W., Sonenberg N.: eIF4E – from translation to transformation. Oncogene, 2004; 23: 3172–3179
- Miki Y., Tanji K., Mori F., Utsumi J., Sasaki H., Kakita A., Takahashi H., Wakabayashi K.: Autophagy mediators (FOXO1, SESN3 and TSC2) in Lewy body disease and aging. Neurosci. Lett., 2018; 684: 35–41
- Mizushima N.: Autophagy: Process and function. Genes Dev., 2007; 21: 2861–2873
- Morrison A., Chen L., Wang J., Zhang M., Yang H., Ma Y., Budanov A., Lee J.H., Karin M., Li J.: Sestrin2 promotes LKB1-mediated AMPK activation in the ischemic heart. FASEB J., 2015; 29: 408–417
- Niture S.K., Khatri R., Jaiswal A.K.: Regulation of Nrf2 – an update. Free Radic. Biol. Med., 2014; 66: 36–44
- Oakhill J.S., Scott J.W., Kemp B.E.: AMPK functions as an adenylate charge-regulated protein kinase. Trends Endocrinol. Metab., 2012; 23: 125–132
- Ozcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Ozdelen E., Tuncman G., Görgün C., Glimcher L.H., Hotamisligil G.S.: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science, 2004; 306: 457–461
- Piantadosi C.A., Carraway M.S., Babiker A., Suliman H.B.: Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ. Res., 2008; 103: 1232–1240
- Pickard L., Palladino G., Okosun J.: Follicular lymphoma genomics. Leuk. Lymphoma, 2020; 61: 2313–2323
- Polewska J.: Autofagia – mechanizm molekularny, apoptoza i nowotwory. Postępy Hig. Med. Dośw., 2012; 66: 921–936
- Quan N., Wang L., Chen X., Luckett C., Cates C., Rousselle T., Zheng Y., Li J.: Sestrin2 prevents age-related intolerance to post myocardial infarction via AMPK/PGC-1α pathway. J. Mol. Cell. Cardiol., 2018; 115: 170–178
- Rai N., Dey S.: Protective response of Sestrin under stressful conditions in aging. Ageing Res. Rev., 2020; 64: 101186
- Reznick R.M., Zong H., Li J., Morino K., Moore I.K., Yu H.J., Liu Z.X., Dong J., Mustard K.J., Hawley S.A., Befroy D., Pypaert M., Hardie D.G., Young L.H., Shulman G.I.: Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab., 2007; 5: 151–156
- Ro S.H., Semple I.A., Park H., Park H., Park H.W., Kim M., Kim J.S., Lee J.H.: Sestrin2 promotes Unc-51-like kinase 1 mediated phosphorylation of p62/sequestosome-1. FEBS J., 2014; 281: 3816–3827
- Sablina A.A.., Budanov A.V., Ilyinskaya G.V., Agapova L.S., Kravchenko J.E., Chumakov P.M.: The antioxidant function of the p53 tumor suppressor. Nat. Med., 2005; 11: 1306–1313
- Sánchez-Álvarez M., Strippoli R., Donadelli M., Bazhin A.V., Cordani M.: Sestrins as a therapeutic bridge between ROS and autophagy in cancer. Cancers, 2019; 11: 1415
- Sanli T., Linher-Melville K., Tsakiridis T., Singh G.: Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells. PLoS One, 2012; 7: e32035
- Saxton R.A., Knockenhauer K.E., Wolfson R.L., Chantranupong L., Pacold M.E., Wang T., Schwartz T.U., Sabatini D.M.: Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway. Science, 2016; 351: 53–58
- Shaw R.J.: LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol., 2009; 196: 65–80
- Shin B.Y., Jin S.H., Cho I.J., Ki S.H.: Nrf2-ARE pathway regulates induction of Sestrin-2 expression. Free Radic. Biol. Med., 2012; 53: 834–841
- Sun G., Xue R., Yao F., Liu D., Huang H., Chen C., Li Y., Zeng J., Zhang G., Dong Y., Liu C.: The critical role of Sestrin 1 in regulating the proliferation of cardiac fibroblasts. Arch. Biochem. Biophys., 2014; 542: 1–6
- Sun W., Wang Y., Zheng Y., Quan N.: The emerging role of sestrin2 in cell metabolism, and cardiovascular and age-related diseases. Aging Dis., 2020; 11: 154–163
- Tao R., Xiong X., Liangpunsakul S., Dong X.C.: Sestrin 3 protein enhances hepatic insulin sensitivity by direct activation of the mTORC2-Akt signaling. Diabetes, 2015; 64: 1211–1223
- Velasco-Miguel S., Buckbinder L., Jean P., Gelbert L., Talbott R., Laidlaw J., Seizinger B., Kley N.: PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene, 1999; 18: 127–137
- Wei J.L., Fu Z.X., Fang M., Guo J.B., Zhao Q.N., Lu W.D., Zhou Q.Y.: Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer. Oncol. Rep., 2015; 33: 1349–1357
- Wolfson R.L., Chantranupong L., Saxton R.A., Shen K., Scaria S.M., Cantor J.R., Sabatini D.M.: Sestrin2 is a leucine sensor for the mTORC1 pathway. Science, 2016; 351: 43–48
- Wullschleger S., Loewith R., Hall M.N.: TOR signaling in growth and metabolism. Cell, 2006; 124: 471–484
- Xie M., Zhang D., Dyck J.R., Li Y., Zhang H., Morishima M., Mann D.L., Taffet G.E., Baldini A., Khoury D.S., Schneider M.D.: A pivotal role for endogenous TGF-β-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc. Natl. Acad. Sci. USA, 2006; 103: 17378–17383
- Xu Y.P., Han F., Tan J.: Edaravone protects the retina against ischemia/reperfusion-induced oxidative injury through the PI3K/Akt/Nrf2 pathway. Mol. Med. Rep., 2017; 16: 9210–9216
- Xue R., Zeng J., Chen Y., Chen C., Tan W., Zhao J., Dong B., Sun Y., Dong Y., Liu C.: Sestrin 1 ameliorates cardiac hypertrophy via autophagy activation. J. Cell. Mol. Med., 2017; 21: 1193–1205
- Yang J.H., Kim K.M., Kim M.G., Seo K.H., Han J.Y., Ka S.O., Park B.H., Shin S.M., Ku S.K., Cho I.J., Ki S.H.: Role of sestrin2 in the regulation of proinflammatory signaling in macrophages. Free Radic. Biol. Med., 2015; 78: 156–167
- Yu R., Chen C., Mo Y.Y., Hebbar V., Owuor E.D., Tan T.H., Kong A.N.: Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. J. Biol. Chem., 2000; 275: 39907–39913
- Yu Y., Yoon S.O., Poulogiannis G., Yang Q., Ma X.M., Villén J., Kubica N., Hoffman G.R., Cantley L.C., Gygi S.P., Blenis J.: Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science, 2011; 332: 1322–1326
- Zhang J.: Teaching the basics of autophagy and mitophagy to redox biologists –mechanisms and experimental approaches. Redox Biol., 2015; 4: 242–259
- Zhang Z., Qian Q., Li M., Shao F., Ding W.X., Lira V.A., Chen S.X., Sebag S.C., Hotamisligil G.S., Cao H., Yang L.: The unfolded protein response regulates hepatic autophagy by sXBP1-mediated activation of TFEB. Autophagy, 2020; DOI: 10.1080/15548627.2020.1788889
- Zhou D., Zhan C., Zhong Q., Li S.: Upregulation of sestrin-2 expression via P53 protects against 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity. J. Mol. Neurosci., 2013; 51: 967–975
- Zighelboim I., Goodfellow P.J., Schmidt A.P., Walls K.C., Mallon M.A., Mutch D.G., Yan P.S., Huang T.H., Powell M.A.: Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers. Clin. Cancer Res., 2007; 13: 2882–2889
DOI: https://doi.org/10.5604/01.3001.0014.9471 | Journal eISSN: 1732-2693
Language: English
Page range: 437 - 447
Submitted on: Jul 11, 2020
Accepted on: Mar 9, 2021
Published on: Jun 18, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2021 Bożena Gabryel, Roksana Duszkiewicz, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.